Where to Buy CJC-1295 + Ipamorelin: A Research Buyer's Guide

The CJC-1295 + Ipamorelin blend is one of the most frequently referenced growth hormone secretagogue combinations in peptide research. It pairs two compounds that both push the pituitary gland to release its own growth hormone (GH), but through separate and complementary mechanisms. Understanding what each molecule is, before deciding where to buy the pair, helps a buyer read a Certificate of Analysis correctly and avoid mislabeled or underdosed products.

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The version most commonly sold in research blends is CJC-1295 without DAC, also known as Modified GRF (1-29) or mod GRF (1-29). It is a 29 amino acid peptide with a molecular weight of roughly 3367.9 g/mol. Without the Drug Affinity Complex (DAC), it has a short half-life measured in minutes rather than days, which is why researchers often pair it with a fast-acting secretagogue rather than using it alone.

Ipamorelin is a pentapeptide (five amino acids: Aib-His-D-2-Nal-D-Phe-Lys-NH₂) with a molecular weight of about 711.85 g/mol. It belongs to the class of growth hormone-releasing peptides (GHRPs) and is considered one of the most selective secretagogues in its category. Unlike older GHRPs, in preclinical work it showed minimal impact on cortisol and prolactin at effective doses, which is a large part of why it is studied so often.

Sold together, the two are usually supplied as a single lyophilized (freeze-dried) powder in one vial, for example a 10 mg or 20 mg total blend. If you want the underlying pharmacology in more depth, our CJC-1295 guide and the dedicated CJC-1295 + Ipamorelin stack article cover each molecule individually. This buying guide focuses strictly on how to source the blend responsibly.

Everything below is provided for educational purposes only. These peptides are research chemicals, not medicines, and nothing here should be read as guidance to use them in humans.

The rationale for the duo comes down to biology: the pituitary responds to two different signals when it releases growth hormone, and CJC-1295 and Ipamorelin each address one of them. Researchers are interested in the combination because activating both pathways at once produces a larger and more physiological GH pulse in preclinical and early clinical models than either compound produces alone.

CJC-1295, the GHRH analog, binds the GHRH receptor on somatotroph cells in the anterior pituitary. This is the primary "go" signal for GH synthesis and release. Because it mimics the body's own releasing hormone, it raises the overall amount of GH available to be released.

Ipamorelin, the selective GHRP, works on a completely separate receptor: the ghrelin receptor (also called the growth hormone secretagogue receptor, or GHS-R). Activating this receptor amplifies the GH pulse and, importantly, suppresses somatostatin, the hormone that normally brakes GH release. In simple terms, one peptide presses the accelerator while the other releases the brake.

Because these actions are additive rather than redundant, the two are studied as a stack rather than as interchangeable options. A researcher choosing between them for a single-agent protocol will find our Ipamorelin vs CJC-1295 comparison useful, while the broader logic of pairing complementary peptides is covered in our peptide stacking guide.

A key practical point for buyers: because CJC-1295 without DAC and Ipamorelin both have short half-lives, a pre-mixed blend is only as good as the accuracy of its stated ratio. This is exactly why the Certificate of Analysis and purity data discussed in the next section matter so much. A vial that claims a 5 mg + 5 mg split but was compounded carelessly does not deliver the balanced dual-pathway signal that motivates the stack in the first place.

When you buy a research peptide, you are effectively buying a promise about what is inside the vial. The only way to hold a supplier to that promise is documentation. For the CJC-1295 + Ipamorelin blend, three quality signals carry the most weight: HPLC purity, a per-batch Certificate of Analysis, and mass spectrometry confirmation of identity.

HPLC purity (High-Performance Liquid Chromatography): This is the single most important number on any peptide report. It tells you what percentage of the material is the intended peptide versus truncated sequences, deletion peptides, and other synthesis byproducts. Reputable research suppliers typically report purity of 98% or higher. A blend report should ideally characterize the mixture and confirm both components are present in the stated proportion.

Certificate of Analysis (CoA) per batch: A generic CoA posted once on a website is far weaker than a document tied to the exact lot number printed on your vial. Peptide synthesis varies from batch to batch, so a per-lot CoA is what lets you confirm that the specific vial in your hand was tested, not a representative sample from a year ago. Look for a matching lot number, a test date, the testing method, and ideally the name of the analytical lab.

Mass spectrometry (MS): HPLC tells you how pure the material is; mass spec confirms it is actually the right molecule by matching the measured molecular weight to the theoretical value (roughly 3367.9 g/mol for CJC-1295 without DAC and 711.85 g/mol for Ipamorelin). Purity without identity confirmation is only half the picture.

Two secondary criteria round out a strong quality profile: sterility and endotoxin considerations for lyophilized powder, and accurate fill weight, meaning the vial actually contains the mass on the label. If a supplier cannot or will not produce HPLC and MS data for the batch you are buying, treat that as a reason to look elsewhere.

Documentation matters, but so does the trustworthiness of the company producing it. A CoA is only meaningful if the supplier is honest about where it came from. Before ordering the CJC-1295 + Ipamorelin blend from anyone, run through a short verification checklist.

Transparent, third-party testing. The strongest suppliers publish batch-level HPLC and mass spec results and are willing to send the CoA for your specific lot on request. Independent, third-party lab testing is more credible than in-house-only claims, because the lab has no incentive to inflate purity.

Honest research-use-only labeling. Legitimate research suppliers label products "for research use only" or "not for human consumption" and do not provide dosing protocols, medical claims, or cure language. A vendor that markets a research peptide as a therapy or promises specific health outcomes is a red flag, both legally and scientifically.

• Contact and business details: a real physical address, a working support channel, and a clear returns or reshipment policy.
• Consistent product data: molecular weight, sequence, and formula that match published literature rather than invented figures.
• Reasonable pricing: prices that are far below the market average often signal underdosed or impure material.
• Storage and reconstitution guidance: a supplier who explains that lyophilized peptide should be kept cold and reconstituted with bacteriostatic water understands the product.
• Reputation: independent reviews and community feedback that discuss actual test results, not just delivery speed.

You can also cross-check a supplier's own claims against neutral references. Our affiliate disclosure explains our commercial relationships transparently, and our medical disclaimer sets out the limits of any information we publish. Verification is not a one-time task; batches change, so it is worth requesting fresh documentation for each order.

For buyers in the European Union, CertaPeptides is a supplier that carries a pre-mixed CJC-1295 + Ipamorelin blend as a single lyophilized product and ships within the EU. It offers the blend in two total masses (a 10 mg vial and a 20 mg vial), which lets a research buyer choose based on how much material a given project needs without compounding two separate vials by hand.

Buying a factory-blended vial has one practical advantage over mixing individual peptides yourself: the ratio between the GHRH analog and the GHRP is fixed at production and documented, rather than depending on your own measuring and reconstitution accuracy. That said, the same quality logic applies. Before ordering, request the batch-specific Certificate of Analysis and confirm that the HPLC purity and mass spec identity are documented for the lot you will receive.

CertaPeptides ships to EU destinations only. Researchers outside the EU will need a supplier that services their region, and should apply the exact same verification checklist described above rather than defaulting to whoever ships fastest. Availability, formats, and stock can change, so always confirm current details on the supplier site.

Two reminders before you order. First, the appropriate way to source these compounds is as research chemicals for laboratory use, consistent with the research-use-only status discussed later in this guide. Second, we maintain commercial affiliate relationships with some suppliers, which we disclose openly in our affiliate disclosure; those relationships do not change the verification standards we recommend. If you are still weighing whether the stack fits your research question at all, revisit the stack overview first.

Price is one input into a buying decision, but with research peptides it should always be read alongside purity and documentation. The cheapest vial is rarely the best value if it lacks a batch CoA, and the most expensive is not automatically the purest. Below are current CertaPeptides list prices for the pre-mixed blend and for the two component peptides sold separately, so you can compare a factory blend against a do-it-yourself pairing.

The table shows why the pre-mixed blend can be attractive on cost alone. A single 20 mg blend vial at 107.99 EUR is priced below buying a 10 mg CJC-1295 vial (71.99 EUR) plus a 10 mg Ipamorelin vial (65.99 EUR) separately, while also removing the need to combine two powders yourself. For a smaller project, the 10 mg blend at 68.49 EUR is the lower entry point.

A note on pricing discipline: prices change frequently, and the figures above are current CertaPeptides list values at the time of writing. Treat any price you see quoted elsewhere with caution, and confirm the live figure on the supplier site before ordering. If you find the blend listed at a fraction of these prices, that is a signal to scrutinize purity documentation more closely, not a bargain to rush.

When comparing value across suppliers, calculate cost per milligram of documented, high-purity peptide rather than cost per vial. A 20 mg vial at 98%+ HPLC purity with a matching batch CoA is worth more than a nominally larger vial with no verifiable testing behind it.

Once you have chosen a supplier and confirmed documentation, the physical handling of the product determines whether it stays intact. Peptides are delicate molecules, and the CJC-1295 + Ipamorelin blend is no exception. Getting shipping and storage right protects the purity you paid for.

Shipping and regional limits. CertaPeptides ships within the European Union only, so confirm your delivery address is serviceable before ordering. Lyophilized (freeze-dried) peptide is relatively stable at room temperature for the short duration of transit, which is why most research suppliers ship the powder rather than a reconstituted solution. Even so, prompt delivery and prompt refrigeration on arrival are ideal.

Storage of the lyophilized powder. Before reconstitution, the sealed vial is generally kept refrigerated and protected from light and moisture; many references cite freezer storage for long-term stability of the dry powder. The key point is that the dry form is far more stable than the dissolved form.

Reconstitution and post-mixing storage. In research settings the powder is reconstituted with bacteriostatic water, after which it must be refrigerated and used within a limited window because the peptide degrades in solution over time. Repeated temperature swings and vigorous shaking both accelerate degradation, so gentle handling matters. A supplier that provides clear reconstitution and storage instructions is demonstrating product competence.

None of the above is a usage protocol. It describes standard laboratory handling of a research reagent so that the material you verified on paper is still intact when you study it. Any decision about what to do with a reconstituted peptide beyond laboratory research falls outside the scope of this guide and should involve a qualified professional.

Before buying, it is essential to understand what CJC-1295 and Ipamorelin are, and are not, in regulatory terms. Both are research peptides. Neither is an approved medicine in the United States or the European Union, and neither is authorized by the FDA or EMA for human use. Products are sold strictly for laboratory research.

Regulatory approval. There is no approved therapeutic product containing CJC-1295 or Ipamorelin for the general population. Early clinical pharmacology studies have examined these secretagogues, but that is very different from marketing authorization. Any supplier presenting them as approved treatments is misrepresenting their status.

Sport and anti-doping. Growth hormone secretagogues, including GHRH analogs and GHRPs, are prohibited under the World Anti-Doping Agency (WADA) framework. Athletes subject to testing should be aware that this class of compound is banned in and out of competition.

Jurisdictional variation. The legality of buying, possessing, and importing research peptides varies significantly by country and can change. Some jurisdictions permit sale for research use only; others restrict import. It is the buyer's responsibility to know the rules that apply where they are, and cross-border shipping does not override local law. This is one more reason CertaPeptides limits shipping to the EU.

This article is provided for educational purposes only and does not constitute medical, legal, or veterinary advice. It contains no dosing recommendations. Consult a qualified healthcare professional before making any decision involving these compounds, and review our full medical disclaimer for the limits of the information published here.